Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Stratmann, Johannes ^a   Wang, Chao Jie ^b   Gnosa, Sebastian ^b   Wallin, Åsa ^b   Hinselwood, David ^b   Sun, Xiao Feng ^b   Zhang, Hong ^a  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

CRC; Dicer; miRNAs; Prognosis; qPCR

Indexed keywords

COMPLEMENTARY DNA; DICER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 141; RNA; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN141 MICRORNA, HUMAN; MIRN200 MICRORNA, HUMAN; MIRN429 MICRORNA, HUMAN; RIBONUCLEASE III;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DICER GENE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; UPREGULATION; COLON TUMOR; COLORECTAL TUMOR; GENETICS; INTESTINE MUCOSA; LIVER TUMOR; METABOLISM; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; RECTUM TUMOR; SURVIVAL;

AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; MALE; MICRORNAS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 81155158414     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-345     Document Type: Article

References (30)

1. Gill S, Thomas RR, Goldberg RM. Review article: colorectal cancer chemotherapy. Aliment Pharmacol Ther 2003, 18:683-692. 10.1046/j.1365-2036.2003.01735.x, 14510741.
2. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932. 10.1056/NEJMra012242, 12621137.
3. Colorectal cancer risk factors.2009. (accessed Feb 2, 2010)., http://www.cdc.gov/cancer/colorectal/basic_info/risk_factors.htm
4. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007, 50:839-855. 10.1007/s10350-006-0848-z, 17308939.
5. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535. 10.1136/gut.48.4.526, 1728259, 11247898.
6. Mott JL. MicroRNAs Involved in Tumor Suppressor and Oncogene Pathways: Implications for Hepatobiliary Neoplasia. Hepatology 2009, 50:630-637. 10.1002/hep.23010, 2721015, 19585622.
7. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269. 10.1038/nrc1840, 16557279.
8. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-Mesenchymal Transitions in Development and Disease. Cell 2009, 139:871-890. 10.1016/j.cell.2009.11.007, 19945376.
9. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Grazia Daidone M, Bicciato S, Piccolo S. A MicroRNA Targeting Dicer for Metastasis Control. Cell 2010, 141:1195-1207. 10.1016/j.cell.2010.05.017, 20603000.
10. Human Protein Atlas. , http://www.proteinatlas.org/gene_info.php?ensembl_gene_id=ENSG00000100697&antibody_id=694
11. Takeshita D, Zenno S, Lee WC, Nagata K, Saigo K, Tanokura M. Homodimeric structure and double-stranded RNA cleavage activity of the C-terminal RNase III domain of human dicer. J Mol Biol 2007, 374:106-120. 10.1016/j.jmb.2007.08.069, 17920623.
12. Merritt WM. Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer. N Engl J Med 2008, 359:2641-2650. 10.1056/NEJMoa0803785, 2710981, 19092150.
13. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma. Cancer Res 2007, 67:2345-2350. 10.1158/0008-5472.CAN-06-3533, 17332367.
14. Karube Y. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005, 96:111-115. 10.1111/j.1349-7006.2005.00015.x, 15723655.
15. Grelier G, Voirin N, Ay A-S, Cox DG, Chabaud S, Treilleux I, Léon-Goddard S, Rimokh R, Mikaelian I, Venoux C, Puisieux A, Lasset C, Moyret-Lalle C. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. BJC 2009, 101:673-683. 10.1038/sj.bjc.6605193, 2736830, 19672267.
16. Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem 2010, 43:324-327. 10.1016/j.clinbiochem.2009.09.014, 19782670.
17. Flavin RJ, Smyth PC, Finn SP, Laios A, O'Toole SA, Barrett C, Ring M, Denning KM, Li J, Aherne ST, Aziz NA, Alhadi A, Sheppard BL, Loda M, Martin C, Sheils OM, O'Leary JJ. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod Pathol 2008, 21:676-684. 10.1038/modpathol.2008.33, 18327211.
18. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R. Up-Regulation of Dicer, a Component of the MicroRNA Machinery, in Prostate Adenocarcinoma. AJP 2006, 169:1812-1820. 1780192, 17071602.
19. Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011, 47:1414-1419. 10.1016/j.ejca.2011.01.006, 21345667.
20. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 2010, 411:1181-1186. 10.1016/j.cca.2010.05.002, 20452339.
21. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589. 10.1038/nature09092, 2995450, 20424607.
22. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, Kornmann M, Ju J. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2006, 2:113-121. 2134920,2134920, 18079988.
23. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009, 8:102. 10.1186/1476-4598-8-102, 2780389, 19912656.
24. Wang CJ, Stratmann J, Zhou ZG, Sun XF. Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and effect cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 2010, 10:616. 10.1186/1471-2407-10-616, 2994822, 21062447.
25. Li F, Lai M. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009, 10:219-229. 10.1631/jzus.B0820273, 2650032, 19283877.
26. Kapiteijn E, Liefers GJ, Los LC, Klein Kranenbarg E, Hermans J, Tollenaar RAEM, Moriya Y, van de Velde CJH, van Krieken JHJM. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001, 195:171-178. 10.1002/path.918, 11592095.
27. Dimberg J, Samuelsson A, Hugander A, Soderkvist P. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 1999, 45:730-732. 10.1136/gut.45.5.730, 1727716, 10517910.
28. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Grazia Daidone M, Leo E, Pilotti S, Bertario L, Pierotti MA. Different Genetic Features Associated with Colon and Rectal Carcinogenesis. Clin Cancer Res 2004, 10:4015-4021. 10.1158/1078-0432.CCR-04-0031, 15217933.
29. Chen LC, Hao CY, Chiu YSY, Wong P, Melnick JS, Brotman M, Moretto J, Mendes F, Smith AP, Bennington JA, Moore D, Lee NM. Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients. Cancer Res 2004, 64:3694-3700. 10.1158/0008-5472.CAN-03-3264, 15150130.
30. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9:582-589. 10.1038/embor.2008.74, 2396950, 18483486.